Trump Administration Official Offers Perspective on TrumpRx: ‘The Goal Was Not Actually Some Massive Reach’
And that official, Chris Klomp, also said that the White House is working on getting drugmaker buy-in on MFN legislation
Mar 20, 2026
Subscribe to Cost Curve Apex to read the rest.
Upgrade to Apex to get access to this post and other subscriber-only content.
Upgrade